SCHEMBL32688149

SCHEMBL32688149

COCCNC(=O)c1cccc(-c2cc(=O)[nH]c(SCc3nnn[nH]3)c2C#N)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TNKS2 Q9H2K2 1/20 0.40
▸ TRPA1 O75762 1/20 0.39
▸ IKBKB O14920 1/20 0.39
▸ KISS1R Q969F8 3/20 0.39
▸ PRKD1 Q15139 1/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ POLB P06746 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ MAP3K5 Q99683 1/20 0.37
▸ ITK Q08881 2/20 0.36
▸ EGLN1 Q9GZT9 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ TGFBR1 P36897 1/20 0.36
▸ LOX P28300 1/20 0.36
▸ LOXL2 Q9Y4K0 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ GPR52 Q9Y2T5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688183 0.90 KISS1R (0.45) IKBKBKISS1RPRKD1KMT2AALDH1A1
SCHEMBL32688014 0.87 ULK1 (0.38) IKBKBKISS1RPRKD1KMT2APOLB
SCHEMBL32688196 0.85 MAPK14 (0.38) IKBKBKMT2AALDH1A1HPGDADORA1
SCHEMBL32688016 0.85 KISS1R (0.42) KISS1RKMT2APOLBALDH1A1LOX
SCHEMBL32688247 0.85 ACMSD (0.44) IKBKBKMT2AALDH1A1HPGDADORA1
SCHEMBL32688271 0.85 ALDH1A1 (0.42) KISS1RKMT2APOLBALDH1A1HPGD
SCHEMBL32688038 0.84 ACMSD (0.45) KMT2APOLBALDH1A1HPGDMEN1
SCHEMBL32688221 0.83 SIRT2 (0.46) KMT2APOLBMEN1MAPT
SCHEMBL32688358 0.81 PSMD14 (0.43) POLBALDH1A1
SCHEMBL32687986 0.79 KMT2A (0.39) KMT2APOLBALDH1A1HPGDADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK TNKS2 3833/4885TRPA1 3024/4885IKBKB 902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback